A logical model of HIV-1 interactions with the T-cell activation signalling pathway

MOTIVATION Human immunodeficiency virus type 1 (HIV-1) hijacks host cellular processes to replicate within its host. Through interactions with host proteins, it perturbs and interrupts signaling pathways that alter key cellular functions. Although networks of viral-host interactions have been relatively well characterized, the dynamics of the perturbation process is poorly understood. Dynamic models of infection have the potential to provide insights into the HIV-1 host interaction. RESULTS We employed a logical signal flow network to model the dynamic interactions between HIV-1 proteins and key human signal transduction pathways necessary for activation of CD4+ T lymphocytes. We integrated viral-host interaction and host signal transduction data into a dynamic logical model comprised of 137 nodes (16 HIV-1 and 121 human proteins) and 336 interactions collected from the HIV-1 Human Interaction Database. The model reproduced expected patterns of T-cell activation, co-stimulation and co-inhibition. After simulations, we identified 26 host cell factors, including MAPK1&3, Ikkb-Ikky-Ikka and PKA, which contribute to the net activation or inhibition of viral proteins. Through in silico knockouts, the model identified a further nine host cell factors, including members of the PI3K signalling pathway that are essential to viral replication. Simulation results intersected with the findings of three siRNA gene knockout studies and identified potential drug targets. Our results demonstrate how viral infection causes the cell to lose control of its signalling system. Logical Boolean modelling therefore provides a useful approach for analysing the dynamics of host-viral interactions with potential applications for drug discovery. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

[1]  L. Staudt,et al.  Active NF-kappaB signalling is a prerequisite for influenza virus infection. , 2004, The Journal of general virology.

[2]  Tomáš Helikar,et al.  A Comprehensive, Multi-Scale Dynamical Model of ErbB Receptor Signal Transduction in Human Mammary Epithelial Cells , 2013, PloS one.

[3]  Amy S. Espeseth,et al.  Genome-scale RNAi screen for host factors required for HIV replication. , 2008, Cell host & microbe.

[4]  X. F. Zhang,et al.  Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.

[5]  G. Koretzky,et al.  T cell activation. , 2009, Annual review of immunology.

[6]  David L Robertson,et al.  HIV-host interactions: a map of viral perturbation of the host system. , 2009, AIDS.

[7]  M. Sheikh,et al.  Death Receptor Activation Complexes: It Takes Two to Activate TNF Receptor 1 , 2003, Cell cycle.

[8]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .

[9]  H. Kwon,et al.  Hostile takeovers: viral appropriation of the NF-kappaB pathway. , 2001, The Journal of clinical investigation.

[10]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[11]  Steffen Klamt,et al.  A Logical Model Provides Insights into T Cell Receptor Signaling , 2007, PLoS Comput. Biol..

[12]  E. Fish,et al.  Chemokines: attractive mediators of the immune response. , 2003, Seminars in immunology.

[13]  Peter M. A. Sloot,et al.  Identifying potential survival strategies of HIV-1 through virus-host protein interaction networks , 2010, BMC Systems Biology.

[14]  J. Margolick,et al.  Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. , 1987, Journal of immunology.

[15]  K. Miller-Jensen,et al.  Systems biology of virus-host signaling network interactions. , 2012, BMB reports.

[16]  H. Kestler,et al.  A Boolean Model of the Cardiac Gene Regulatory Network Determining First and Second Heart Field Identity , 2012, PloS one.

[17]  Sébastien Lê,et al.  A new unsupervised gene clustering algorithm based on the integration of biological knowledge into expression data , 2013, BMC Bioinformatics.

[18]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[19]  Donna R. Maglott,et al.  Human immunodeficiency virus type 1, human protein interaction database at NCBI , 2008, Nucleic Acids Res..

[20]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[21]  F. Ennis,et al.  Influenza virus infection in nude mice. , 1976, The Journal of infectious diseases.

[22]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[23]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[24]  R. König,et al.  Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication , 2008, Cell.

[25]  V. Boussiotis,et al.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A , 2012, Cell cycle.

[26]  C. Dermardirossian,et al.  p21-activated Kinase 1 Phosphorylates and Regulates 14-3-3 Binding to GEF-H1, a Microtubule-localized Rho Exchange Factor* , 2004, Journal of Biological Chemistry.

[27]  K. Takase,et al.  [T cell activation]. , 1995, Ryumachi. [Rheumatism].

[28]  T. Nikolskaya,et al.  Biological networks and analysis of experimental data in drug discovery. , 2005, Drug discovery today.

[29]  David L. Robertson,et al.  The biological context of HIV-1 host interactions reveals subtle insights into a system hijack , 2010, BMC Systems Biology.

[30]  A. Lanfranco,et al.  CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms , 2004, Molecular and Cellular Biology.

[31]  E. Kranias,et al.  Phospholamban: a key determinant of cardiac function and dysfunction. , 2005, Archives des maladies du coeur et des vaisseaux.

[32]  Amy S. Espeseth,et al.  Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies , 2009, PLoS pathogens.

[33]  Steffen Klamt,et al.  A methodology for the structural and functional analysis of signaling and regulatory networks , 2006, BMC Bioinformatics.

[34]  David L Robertson,et al.  Cataloguing the HIV type 1 human protein interaction network. , 2008, AIDS research and human retroviruses.

[35]  G. Nabel,et al.  Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Steffen Klamt,et al.  Structural and functional analysis of cellular networks with CellNetAnalyzer , 2007, BMC Systems Biology.

[37]  J. Penninger,et al.  From T‐cell activation signals to signaling control of anti‐cancer immunity , 2007, Immunological reviews.

[38]  Chris T. A. Evelo,et al.  WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..